Mitochondrial Superoxide Dismutase in Cisplatin-Induced Kidney Injury

Volume: 10, Issue: 9, Pages: 1329 - 1329
Published: Aug 24, 2021
Abstract
Cisplatin is a chemotherapy agent commonly used to treat a wide variety of cancers. Despite the potential for both severe acute and chronic side effects, it remains a preferred therapeutic option for many malignancies due to its potent anti-tumor activity. Common cisplatin-associated side-effects include acute kidney injury (AKI) and chronic kidney disease (CKD). These renal injuries may cause delays and potentially cessation of cisplatin...
Paper Details
Title
Mitochondrial Superoxide Dismutase in Cisplatin-Induced Kidney Injury
Published Date
Aug 24, 2021
Volume
10
Issue
9
Pages
1329 - 1329
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.